EP0545000A1 - An improved vessel for perfusion liquids - Google Patents

An improved vessel for perfusion liquids Download PDF

Info

Publication number
EP0545000A1
EP0545000A1 EP92114011A EP92114011A EP0545000A1 EP 0545000 A1 EP0545000 A1 EP 0545000A1 EP 92114011 A EP92114011 A EP 92114011A EP 92114011 A EP92114011 A EP 92114011A EP 0545000 A1 EP0545000 A1 EP 0545000A1
Authority
EP
European Patent Office
Prior art keywords
vessel
tube
perfusion liquids
improved
containing perfusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP92114011A
Other languages
German (de)
French (fr)
Other versions
EP0545000B1 (en
Inventor
Victor Grifols Lucas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0545000A1 publication Critical patent/EP0545000A1/en
Application granted granted Critical
Publication of EP0545000B1 publication Critical patent/EP0545000B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10Bag-type containers

Definitions

  • This invention refers to an improved vessel for containing perfusion liquids offering important novel characteristics in its utilization with respect to currently known vessels used for this purpose.
  • Perfusion liquid containers are used generally for the various types of fluids destined for perfusion or injection in the human body, their particular requirement being that they should contain the said fluid under sterile conditions which condition must be maintained up to the moment of the application of the fluid in a clinical operation.
  • This invention refers to an improved perfusion liquid vessel having important advantages as against existing containers in that the requirement for sterile enclosures for sterilizing the liquid to be contained in the vessel is no longer necessary (or even in the absence of this requirement ), sterility is maintained up to the moment of use and an automatic control system can be applied to ensure that the procedure has been correct.
  • the vessel which is the object of this invention is characterized by having built therein a tube for filling the vessel and which tube has integral with it and inalienable thereto a sterilizing membrane filter with a porosity of between 0,20 and 0,25 microns, for preference being 0,22 microns maximum, such that filling the vessel is coincident with a sterilization action and then, having filled the vessel, given the considerable capilliary force exercised in passages of this fineness, air flow is prevented unless the pressure attains some 3 bars, this phenomenum permitting verification and eventually the integrity and correct operation of the filter.
  • Figure 1 shows a frontal view of the vessel in its vertical position.
  • Figure 2 is a cross sectional view on the plane so indicated in figure 1.
  • Figure 3 shows the detail of the filling tube assembly with its incorporated filter in cross-section.
  • Figure 4 is a cross sectional view on the plane so indicated in figure 3.
  • Figure 5 is a cross sectional view on the plane so indicated in figure 3.
  • this invention is characterized in that it comprises a vessel -1-, made of a synthetic material that is clinically compatible having a flattened form generally, the front and rear faces -2- and -3- respectively being generally planar with the upper and lower zones -4- and -5- being formed with half round or similar ribbing or projections so as to provide an adequate stiffness and strength to those areas.
  • the upper zone -5- has incorporated therein the filling tube -6- with the sterilization filter -7- in its upper part, integral with it and forming part of the inviolable system of a non-detachable assembly.
  • the filter has a porosity of between 0,20 and 0,25 microns, but preferably not exceeding 0,22 microns such that the vessel can be filled with the perfusion fluid through the tube -6- while the fluid's passage through the filter -7- effects its sterilization and thereafter this same filter with its above dimensioned pores operates as a stopper or closure in that for air to infiltrate through it a pressure of some 3 bars would have to be applied, this feature also providing an effective control by which the sterilizing characteristic of the filter may be monitored.
  • the vessel is also provided with an access tube -8- parallel to the filling tube incorporating a thin diaphragm -9- which can be perforated by the needle of the perfusion catheter feed tube.
  • an access tube -8- parallel to the filling tube incorporating a thin diaphragm -9- which can be perforated by the needle of the perfusion catheter feed tube.
  • Figure 3 shows the filter -7- as having two flat components -12- and -13- joined together by welding or pressing, the piece -13- having as part of it the filler tube -14- and the piece -12- being extended by a tubular connection -15- for attachment by welding or adhesive to the upper end of the tubular component -6-.

Landscapes

  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

The vessel (1) for perfusion liquids of the type which is closed at one extremity (4) and having a filling orifice (6) at the other (5) with a zone (8) for the insertion of a syringe or abstraction needle of the catheter supply tube, the vessel (1) being characterized by having incorporated therein integrally and inviolably a microfilter (7) for wet filtration preventing the passage of air under atmospheric pressure and permitting its correct functioning without dismantling the sterilized assembly.

Description

  • This invention refers to an improved vessel for containing perfusion liquids offering important novel characteristics in its utilization with respect to currently known vessels used for this purpose.
  • Perfusion liquid containers are used generally for the various types of fluids destined for perfusion or injection in the human body, their particular requirement being that they should contain the said fluid under sterile conditions which condition must be maintained up to the moment of the application of the fluid in a clinical operation.
  • Current practice is to sterilize the vessel which already contains the fluid for therapeutic use should the fluid be able to tolerate this procedure or in the contrary case, to sterilize the vessel prior to its filling and then carry out the filling operation in a sterile enclosure so as to preserve the required sterile condition of the fluid to be fed into the vessel and that of the vessel itself.
  • This invention refers to an improved perfusion liquid vessel having important advantages as against existing containers in that the requirement for sterile enclosures for sterilizing the liquid to be contained in the vessel is no longer necessary (or even in the absence of this requirement ), sterility is maintained up to the moment of use and an automatic control system can be applied to ensure that the procedure has been correct.
  • Essentially, the vessel which is the object of this invention is characterized by having built therein a tube for filling the vessel and which tube has integral with it and inalienable thereto a sterilizing membrane filter with a porosity of between 0,20 and 0,25 microns, for preference being 0,22 microns maximum, such that filling the vessel is coincident with a sterilization action and then, having filled the vessel, given the considerable capilliary force exercised in passages of this fineness, air flow is prevented unless the pressure attains some 3 bars, this phenomenum permitting verification and eventually the integrity and correct operation of the filter. This effect facilitates the control of the filter's correct operation since due to the surface tension in the fine passages of the filter the above pressure is required to overcome this tension and allow air to infiltrate the vessel. Hence after the operation of filling the vessel, in order to check the filter effectiveness an air pressure is applied equivalent to the surface tension produced in the filter and at that point no bubbles should be observed forming in the vessel. This bubble point, measured by the air pressure that the filter is resisting presents a simple method for determining the integrity of filter itself.
  • To assist the explanation explanatory drawings are attached showing one embodiment, by way of example, of a liquid perfusion vessel in accordance with this present invention.
  • Figure 1 shows a frontal view of the vessel in its vertical position.
  • Figure 2 is a cross sectional view on the plane so indicated in figure 1.
  • Figure 3 shows the detail of the filling tube assembly with its incorporated filter in cross-section.
  • Figure 4 is a cross sectional view on the plane so indicated in figure 3.
  • Figure 5 is a cross sectional view on the plane so indicated in figure 3.
  • As can be seen in the drawings this invention is characterized in that it comprises a vessel -1-, made of a synthetic material that is clinically compatible having a flattened form generally, the front and rear faces -2- and -3- respectively being generally planar with the upper and lower zones -4- and -5- being formed with half round or similar ribbing or projections so as to provide an adequate stiffness and strength to those areas.
  • The upper zone -5- has incorporated therein the filling tube -6- with the sterilization filter -7- in its upper part, integral with it and forming part of the inviolable system of a non-detachable assembly. The filter has a porosity of between 0,20 and 0,25 microns, but preferably not exceeding 0,22 microns such that the vessel can be filled with the perfusion fluid through the tube -6- while the fluid's passage through the filter -7- effects its sterilization and thereafter this same filter with its above dimensioned pores operates as a stopper or closure in that for air to infiltrate through it a pressure of some 3 bars would have to be applied, this feature also providing an effective control by which the sterilizing characteristic of the filter may be monitored.
  • The vessel is also provided with an access tube -8- parallel to the filling tube incorporating a thin diaphragm -9- which can be perforated by the needle of the perfusion catheter feed tube. There is also fitted to the upper part of the orifice -8- a further stopper or plug -10- with a tab -11- attached thereto to facilitate its opening but ensuring its closure until the time of its utilization.
  • Figure 3 shows the filter -7- as having two flat components -12- and -13- joined together by welding or pressing, the piece -13- having as part of it the filler tube -14- and the piece -12- being extended by a tubular connection -15- for attachment by welding or adhesive to the upper end of the tubular component -6-.
  • By means of the above disclosed invention it is acceptable to fill the vessel -1- in surroundings which may not necessarily be sterilized thus simplifying the operation and lessening the cost thereof as well as increasing security. Nevertheless the sterilization both during and after filling is assured by the specific characteristics of the filter preventing the entry of any particles exceeding the dimensions as foreseen for the sterilization effect and at the same time providing an effective impediment to the entry of external air and permitting a monitoring of the filtration effectiveness.

Claims (6)

  1. An improved vessel for containing perfusion liquids, having a flattened form, closed at one extremity and having at the other extremity an opening for filling the vessel and having also a zone where the syringe or abstraction needle of a catheter feed tube can be inserted, the vessel being characterized in that it is provided with an integral and inviolable wet microfilter preventing the passage of air under atmospheric pressure and which permits its correct functioning to be verified without dismantling the sterilized assembly.
  2. An improved vessel for containing perfusion liquids as in claim 1. characterized in that the microfilter has a porosity of approximately 0,20 to 0,25 microns, preferably with a maximum of 0,22 microns.
  3. An improved vessel for containing perfusion liquids, as in claim 2, characterized by the filter consisting of two plates mutually joined together with rounded or curved grooving on their mutually facing surfaces, one of the pieces having a filling orifice and the other a connecting member for joining to a tube incorporated within the vessel by means of an adhesive or by welding.
  4. An improved vessel for containing perfusion liquids as in claim 1, characterized by the provision of a tubular entry parallel to the incorporated tube and having at some intermediate position a closure part of which is a thin diaphragm for the introduction of the syringe or abstraction needle of a catheter feed.
  5. An improved vessel for containing perfusion liquids as in claim 4, characterized in that the tube through which the fluid is abstracted has at its upper extremity a closure which can be opened manually.
  6. An improved vessel for containing perfusion liquids as in claim 5, characterized in that the vessel has at its upper part a detachable element having two tubular bodies, one of which can accept the tube for filling the vessel and the other having a diaphragm which can be pierced by the abstraction needle for supply to the catheter and the manually operated closure tab.
EP92114011A 1991-12-05 1992-08-17 An improved vessel for perfusion liquids Expired - Lifetime EP0545000B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES19919103692U ES1019546Y (en) 1991-12-05 1991-12-05 PERFUSION LIQUID BAG, PERFECTED.
ES9103692U 1991-12-05

Publications (2)

Publication Number Publication Date
EP0545000A1 true EP0545000A1 (en) 1993-06-09
EP0545000B1 EP0545000B1 (en) 1997-10-29

Family

ID=8275372

Family Applications (1)

Application Number Title Priority Date Filing Date
EP92114011A Expired - Lifetime EP0545000B1 (en) 1991-12-05 1992-08-17 An improved vessel for perfusion liquids

Country Status (10)

Country Link
EP (1) EP0545000B1 (en)
JP (1) JP2622056B2 (en)
AT (1) ATE159653T1 (en)
BR (1) BR7201541U (en)
CH (1) CH687585A5 (en)
DE (1) DE69222922T2 (en)
ES (2) ES1019546Y (en)
IT (1) IT1261651B (en)
MX (1) MX64B (en)
PT (1) PT100782B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI108514B (en) * 1993-06-25 2002-02-15 Cusi Lab Use of polymer membranes in the distribution of pharmaceutical solutions containing quaternary ammonium compounds as preservatives
ES2070777B1 (en) * 1993-10-05 1995-12-16 Mejias David Gonzalez SANITARY CONTAINER FOR URINE ANALYSIS WITH FEMALE ADAPTER.
DE60217201T2 (en) 2001-02-28 2007-11-08 Grifols, S.A. Apparatus for filling containers for pharmaceutical purposes and the like
CN108473218B (en) 2016-01-22 2019-07-19 巴克斯特国际公司 For producing the method and machine of sterile solution product bag
NZ743293A (en) 2016-01-22 2019-05-31 Baxter Healthcare Sa Sterile solutions product bag
FI3715632T3 (en) 2019-03-26 2023-06-02 Grifols Sa Method for calibrating a peristaltic pump, method for dispensing a quantity of liquid by means of a peristaltic pump and device for producing sterile preparations that can execute said methods

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265242A (en) * 1979-07-23 1981-05-05 Cohen Milton J Filter device for injectable fluid
US4265760A (en) * 1979-02-26 1981-05-05 Becton Dickinson & Company Device for dilution and delivery of in vivo chemicals
EP0116362A2 (en) * 1983-02-11 1984-08-22 Millipore Corporation Sterile package for therapeutic composition
FR2545376A1 (en) * 1983-05-03 1984-11-09 Sartorius Gmbh SMALL FILTER FOR GAS FILTRATION
DE3333283A1 (en) * 1983-09-15 1985-04-18 Gerhard 3429 Krebeck Lorenz Treatment system for infusion solutions
US4906103A (en) * 1984-05-30 1990-03-06 Ti Kao Devices and methods for preparing a solution for medicinal purposes
WO1992012697A1 (en) * 1991-01-29 1992-08-06 Baxter International Inc. System for creating at a site, remote from a sterile environment, a parenteral solution

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265760A (en) * 1979-02-26 1981-05-05 Becton Dickinson & Company Device for dilution and delivery of in vivo chemicals
US4265242A (en) * 1979-07-23 1981-05-05 Cohen Milton J Filter device for injectable fluid
EP0116362A2 (en) * 1983-02-11 1984-08-22 Millipore Corporation Sterile package for therapeutic composition
FR2545376A1 (en) * 1983-05-03 1984-11-09 Sartorius Gmbh SMALL FILTER FOR GAS FILTRATION
DE3333283A1 (en) * 1983-09-15 1985-04-18 Gerhard 3429 Krebeck Lorenz Treatment system for infusion solutions
US4906103A (en) * 1984-05-30 1990-03-06 Ti Kao Devices and methods for preparing a solution for medicinal purposes
WO1992012697A1 (en) * 1991-01-29 1992-08-06 Baxter International Inc. System for creating at a site, remote from a sterile environment, a parenteral solution

Also Published As

Publication number Publication date
PT100782A (en) 1994-05-31
ITMI922073A0 (en) 1992-09-07
CH687585A5 (en) 1997-01-15
MX64B (en) 1993-08-03
ATE159653T1 (en) 1997-11-15
ITMI922073A1 (en) 1993-06-06
DE69222922D1 (en) 1997-12-04
ES1019546Y (en) 1992-11-01
PT100782B (en) 1999-09-30
EP0545000B1 (en) 1997-10-29
ES1019546U (en) 1992-04-01
JPH05212115A (en) 1993-08-24
IT1261651B (en) 1996-05-28
BR7201541U (en) 1993-08-03
JP2622056B2 (en) 1997-06-18
DE69222922T2 (en) 1998-04-09
ES2110457T3 (en) 1998-02-16

Similar Documents

Publication Publication Date Title
JP2001198226A (en) Sterilizing state keeping connection system for medical system, female connection element and male connection element, and method of using sterilizing state keeping connection system for medical system
US5219101A (en) Contamination-resistant dispensing and metering drop forming device
US5265770A (en) Contamination-resistant dispensing and metering device
JP3618752B2 (en) Liquid container with dual-purpose access port
JP4533887B2 (en) Connector for pack containing medical fluid and pack for medical fluid
US6345553B1 (en) Ink application device for tattooing or for making permanent make-up
JPH0436704B2 (en)
MXPA06004241A (en) Connector for medical liquid-containing packages and medical liquid-containing packages.
JPH01501920A (en) Sterile one-piece container and fluid transfer set
GB2104044A (en) Bag and valve assembley for medical use
EP0545000A1 (en) An improved vessel for perfusion liquids
DE1087324B (en) Infusion device
JPH08168530A (en) Insulin injector
US5342345A (en) Solution bag with plastic connecting tube
JP2002224195A (en) Transfusion container
DE102008057822B4 (en) Device for storage and dermal administration of a substance
NZ563449A (en) A line, such as a line of a blood tubing, with plastically deformable closure member in line
EP0401022B1 (en) Contamination-resistant dispensing and metering device
US5122126A (en) Nozzle member provided with sealing membrane
JPH0585557A (en) Cap for distributing liquid from vessel and liquid distributor
EP1882486A1 (en) Device for handling perfusion liquids with membrane filter and anti-tamper means
DE2844206A1 (en) Protective cap for vessel mouth - has disc containing perforation point below removable section of end wall formed integral with cylindrical part of cap housing
US6544250B1 (en) Blind clinical trial device
WO1996026701A1 (en) System for enteral/parenteral administration of a substance
EP2756854A1 (en) Medical fluid bag

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE DE DK ES FR GB NL SE

17P Request for examination filed

Effective date: 19931108

17Q First examination report despatched

Effective date: 19950309

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE DE DK ES FR GB NL SE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19971029

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19971029

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 19971029

Ref country code: DK

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19971029

REF Corresponds to:

Ref document number: 159653

Country of ref document: AT

Date of ref document: 19971115

Kind code of ref document: T

REF Corresponds to:

Ref document number: 69222922

Country of ref document: DE

Date of ref document: 19971204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19980129

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2110457

Country of ref document: ES

Kind code of ref document: T3

ET Fr: translation filed
NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

REG Reference to a national code

Ref country code: GB

Ref legal event code: 732E

REG Reference to a national code

Ref country code: FR

Ref legal event code: TP

REG Reference to a national code

Ref country code: FR

Ref legal event code: CA

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20101029

Year of fee payment: 19

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20110610

Year of fee payment: 20

Ref country code: ES

Payment date: 20110603

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20110629

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69222922

Country of ref document: DE

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69222922

Country of ref document: DE

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20120816

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20120816

Ref country code: DE

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20120818

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20121207

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20120818